{
    "body_text": [
        {
            "endOffset": 9262,
            "parents": [],
            "secId": "sec0010",
            "sentence": "The dashed lines represent 1 \u2212 \u03c3, which we set at the level of the highest protection estimate from any of the studies.",
            "startOffset": 9143,
            "title": "Relaxing the model and adjusting the data"
        },
        {
            "endOffset": 10133,
            "parents": [],
            "secId": "sec0010",
            "sentence": "This results in disease rates that decrease over time [14], an output that can be tested against time-to-event data.",
            "startOffset": 10017,
            "title": "Relaxing the model and adjusting the data"
        },
        {
            "endOffset": 12806,
            "parents": [],
            "secId": "sec0015",
            "sentence": "Each data point comes from a country where a trial has been conducted to estimate the efficacy of a specific vaccine (colour coded by continent).",
            "startOffset": 12661,
            "title": "Observations from vaccine trials"
        },
        {
            "endOffset": 8338,
            "parents": [],
            "secId": "sec0005",
            "sentence": "As noted by Smith et al. [6], this measure based on rate ratios is independent of time while a measure based on risk ratios declines over time from the beginning of the trial due to depletion of individuals at risk.",
            "startOffset": 8123,
            "title": "Minimal model for a clinical trial"
        },
        {
            "endOffset": 13003,
            "parents": [],
            "secId": "sec0015",
            "sentence": "Dotted lines represent average estimates reported in the original publications: BCG against pulmonary tuberculosis [1]; RotaTeq against rotavirus gastroenteritis [2\u20134]; RTS,S against malaria [10].",
            "startOffset": 12807,
            "title": "Observations from vaccine trials"
        },
        {
            "endOffset": 10256,
            "parents": [],
            "secId": "sec0010",
            "sentence": "This effect is more pronounced in the control group as individuals within it experience higher rates of infection overall.",
            "startOffset": 10134,
            "title": "Relaxing the model and adjusting the data"
        },
        {
            "endOffset": 13254,
            "parents": [],
            "secId": "sec0015",
            "sentence": "When variation in vaccine effects is large, pooled estimates have little meaning as seen by comparing the dotted lines with the data points.",
            "startOffset": 13114,
            "title": "Observations from vaccine trials"
        },
        {
            "endOffset": 13040,
            "parents": [],
            "secId": "sec0015",
            "sentence": "Three points are worth highlighting.",
            "startOffset": 13004,
            "title": "Observations from vaccine trials"
        },
        {
            "endOffset": 14359,
            "parents": [],
            "secId": "sec0020",
            "sentence": "Adjusting models to global data requires flexible distributions of individual disease risk to be implemented, which can also be estimated in this process [19,20].",
            "startOffset": 14197,
            "title": "Improving estimations from trials"
        },
        {
            "endOffset": 11143,
            "parents": [],
            "secId": "sec0010",
            "sentence": "In the case of rotavirus and malaria vaccines, we refer to recent trials, which conform with standardized multicenter designs, a highly desirable attribute for global analyses such as this.",
            "startOffset": 10954,
            "title": "Relaxing the model and adjusting the data"
        },
        {
            "endOffset": 12562,
            "parents": [],
            "secId": "sec0010",
            "sentence": "The field would gain substantially if individual patient data were deposited in repositories such as ImmPort or other public portals.",
            "startOffset": 12429,
            "title": "Relaxing the model and adjusting the data"
        },
        {
            "endOffset": 13887,
            "parents": [],
            "secId": "sec0020",
            "sentence": "There is overwhelming evidence that vaccine efficacy, as commonly estimated in randomized controlled trials, decreases with increasing disease incidence, but these observations can be reconciled by making the analysis less rigid.",
            "startOffset": 13658,
            "title": "Improving estimations from trials"
        },
        {
            "endOffset": 10701,
            "parents": [],
            "secId": "sec0010",
            "sentence": "To illustrate the effect just described, we use a gamma distribution to represent heterogeneity in individual disease risk and generate the set of curves added to the plots in Fig. 1.",
            "startOffset": 10518,
            "title": "Relaxing the model and adjusting the data"
        },
        {
            "endOffset": 11514,
            "parents": [],
            "secId": "sec0010",
            "sentence": "In any case, the trend of falling vaccine efficacy with rising disease incidence can be explained by a simple selection mechanism, which is not accounted for in standard trial analyses.",
            "startOffset": 11329,
            "title": "Relaxing the model and adjusting the data"
        },
        {
            "endOffset": 14196,
            "parents": [],
            "secId": "sec0020",
            "sentence": "This universal efficacy quantity can be derived, by fitting the model to vaccine trial data over a gradient of incidences.",
            "startOffset": 14074,
            "title": "Improving estimations from trials"
        },
        {
            "endOffset": 12179,
            "parents": [],
            "secId": "sec0010",
            "sentence": "Vaccine efficacy is then defined as 1 \u2212 \u03c3, representing, effectively, a measure of efficacy per unit of exposure, which has a clear interpretation and can be used to parameterize predictive models of vaccine protection in different incidence settings [15].",
            "startOffset": 11923,
            "title": "Relaxing the model and adjusting the data"
        },
        {
            "endOffset": 14844,
            "parents": [],
            "secId": "sec0020",
            "sentence": "For illustration, we have chosen three vaccines that have undergone randomized controlled trials throughout the globe (BCG against pulmonary tuberculosis [1], RotaTeq against rotavirus gastroenteritis [2\u20134] and RTS,S against malaria [10]), but the procedure is applicable more generally to vaccines and other interventions against not only infectious diseases, but also non-communicable disorders provided that information is available on exposure intensity to a specific risk factor.",
            "startOffset": 14360,
            "title": "Improving estimations from trials"
        },
        {
            "endOffset": 8568,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Here, however, we are more interested in stressing independence on the intensity of transmission that governs the incidence of disease, and focus on rate ratios while Margheri et al. [9] elaborates on both rate and risk measures.",
            "startOffset": 8339,
            "title": "Minimal model for a clinical trial"
        },
        {
            "endOffset": 8122,
            "parents": [],
            "secId": "sec0005",
            "sentence": "The efficacy of the vaccine is then represented by 1 \u2212 rv/rc = 1 \u2212 \u03c3.",
            "startOffset": 8053,
            "title": "Minimal model for a clinical trial"
        },
        {
            "endOffset": 13624,
            "parents": [],
            "secId": "sec0015",
            "sentence": "The third is that the efficacy parameter obtained by this procedure approximates the vaccine effect per unit of exposure [5].",
            "startOffset": 13499,
            "title": "Observations from vaccine trials"
        },
        {
            "endOffset": 13498,
            "parents": [],
            "secId": "sec0015",
            "sentence": "The second is that a suitable mathematical model can generate a family of curves that describe the observed trends, and the parameters that identify the best fitting curve can be estimated by available statistical inference procedures [16\u201318].",
            "startOffset": 13255,
            "title": "Observations from vaccine trials"
        },
        {
            "endOffset": 10434,
            "parents": [],
            "secId": "sec0010",
            "sentence": "Consequently, the ratio of disease rates in vaccinated over control groups increases, and vaccine efficacy, as measured by simple rate ratios, decreases as the trial progresses.",
            "startOffset": 10257,
            "title": "Relaxing the model and adjusting the data"
        },
        {
            "endOffset": 10953,
            "parents": [],
            "secId": "sec0010",
            "sentence": "Solid curves, corresponding to 1-year follow-up, are labeled by the variance of the respective gamma distribution, which can be adjusted for best fitting the data (for the malaria trial we used a modified model to account for repeated infections [9]).",
            "startOffset": 10702,
            "title": "Relaxing the model and adjusting the data"
        },
        {
            "endOffset": 15213,
            "parents": [],
            "secId": "sec0020",
            "sentence": "Per-exposure efficacy can be estimated by fitting models to data from multicenter clinical trials, ideally with study sites selected as to cover the largest possible range of transmission intensities.",
            "startOffset": 15013,
            "title": "Improving estimations from trials"
        },
        {
            "endOffset": 11328,
            "parents": [],
            "secId": "sec0010",
            "sentence": "The original publications report follow-up periods of 2 years for rotavirus [2\u20134] and 4 years for malaria [10], and these prolonged durations are represented by the dash-dotted curves.",
            "startOffset": 11144,
            "title": "Relaxing the model and adjusting the data"
        },
        {
            "endOffset": 15012,
            "parents": [],
            "secId": "sec0020",
            "sentence": "We hope to have laid the basis for further research on this important topic where methodological development can be as elaborate as the detail in available data allows.",
            "startOffset": 14844,
            "title": "Improving estimations from trials"
        },
        {
            "endOffset": 8778,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Despite these theoretical notions of independence, we encounter a consistent trend of decreasing vaccine efficacy with increasing force of infection when estimated by conventional randomized controlled trials.",
            "startOffset": 8569,
            "title": "Minimal model for a clinical trial"
        },
        {
            "endOffset": 12428,
            "parents": [],
            "secId": "sec0010",
            "sentence": "The procedure can be refined as much as detailed attributes of trial participants and pathogen types are collected and modeled, although this requires access to original individual data, rather than the aggregate measures that are usually published.",
            "startOffset": 12179,
            "title": "Relaxing the model and adjusting the data"
        },
        {
            "endOffset": 8052,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Following Smith et al. [6] and Halloran et al. [7] for leaky vaccines, we denote by rc = \u03bb the per capita rate of infection of unvaccinated individuals (force of infection) and by rv = \u03c3\u03bb the reduced rate of infection in vaccinated subjects.",
            "startOffset": 7811,
            "title": "Minimal model for a clinical trial"
        },
        {
            "endOffset": 9458,
            "parents": [],
            "secId": "sec0010",
            "sentence": "As changing \u03c3 basically moves the lines up and down, it is evident that this cannot satisfactorily fit the trends for reduced vaccine protection with increased incidence seen from real life data.",
            "startOffset": 9263,
            "title": "Relaxing the model and adjusting the data"
        },
        {
            "endOffset": 14073,
            "parents": [],
            "secId": "sec0020",
            "sentence": "We show that a plausible model can reproduce the incidence-dependent observations when adequately parameterized and give a vaccine efficacy measurement that is valid for all incidences.",
            "startOffset": 13888,
            "title": "Improving estimations from trials"
        },
        {
            "endOffset": 15659,
            "parents": [],
            "secId": "sec0020",
            "sentence": "Further studies are needed to identify how much of the trend can be explained by the mathematical argument offered here.",
            "startOffset": 15539,
            "title": "Improving estimations from trials"
        },
        {
            "endOffset": 13113,
            "parents": [],
            "secId": "sec0015",
            "sentence": "The first concerns the reporting of overall estimates taken as averages.",
            "startOffset": 13041,
            "title": "Observations from vaccine trials"
        },
        {
            "endOffset": 7810,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Any analysis of a vaccine trial must compare the incidence of disease in two groups of the population that are differentiated by whether or not they have received the vaccine, here named the vaccine group and the control group.",
            "startOffset": 7583,
            "title": "Minimal model for a clinical trial"
        },
        {
            "endOffset": 10518,
            "parents": [],
            "secId": "sec0010",
            "sentence": "Finally, the magnitude of this effect increases with the intensity of transmission.",
            "startOffset": 10435,
            "title": "Relaxing the model and adjusting the data"
        },
        {
            "endOffset": 9142,
            "parents": [],
            "secId": "sec0010",
            "sentence": "These are plotted in Fig. 1 to illustrate our argument (see appendix for tables).",
            "startOffset": 9061,
            "title": "Relaxing the model and adjusting the data"
        },
        {
            "endOffset": 11922,
            "parents": [],
            "secId": "sec0010",
            "sentence": "The approach involves fitting a curve to estimate two parameters: the risk ratio of vaccine over control groups, \u03c3; and the variance of the risk distribution in control groups, q(x).",
            "startOffset": 11740,
            "title": "Relaxing the model and adjusting the data"
        },
        {
            "endOffset": 15538,
            "parents": [],
            "secId": "sec0020",
            "sentence": "The two viewpoints are not exclusive but complementary, with the possibility of each only partially explaining the observations.",
            "startOffset": 15410,
            "title": "Improving estimations from trials"
        },
        {
            "endOffset": 9060,
            "parents": [],
            "secId": "sec0010",
            "sentence": "We extracted data on vaccine protection for tuberculosis (bacille Calmette-Gu\u00e9rin, BCG [1]), rotavirus (pentavalent rotavirus vaccine, RotaTeq [2\u20134]), and malaria (RTS,S [10]), from systematic reviews and recent multicenter clinical trials.",
            "startOffset": 8820,
            "title": "Relaxing the model and adjusting the data"
        },
        {
            "endOffset": 15896,
            "parents": [],
            "secId": "sec0020",
            "sentence": "Dose\u2212response experimental challenge systems are ideally suited to this objective [8], and the recent attention devoted to the establishment of safe protocols applicable to human volunteers offers a unique and exciting opportunity [21].",
            "startOffset": 15660,
            "title": "Improving estimations from trials"
        },
        {
            "endOffset": 15409,
            "parents": [],
            "secId": "sec0020",
            "sentence": "While here we focus on the mathematical basis for the reported trends, large studies are in progress to unravel biological determinants of immune response to vaccines in a setting-specific manner.",
            "startOffset": 15213,
            "title": "Improving estimations from trials"
        },
        {
            "endOffset": 9862,
            "parents": [],
            "secId": "sec0010",
            "sentence": "Based on the fact that individual risks of infection and disease are not homogeneous even in local settings, a model can be developed that accounts for heterogeneous distributions of individual risks [9,11], resulting in instantaneous rates written as rc(t) = \u222b \u03bbxe\u2212\u03bbxtq(x)dx/\u222b e\u2212\u03bbxtq(x)dx and rv(t) = \u222b \u03c3\u03bbx e\u2212\u03c3\u03bbxtq(x)dx/\u222b e\u2212\u03c3\u03bbxtq(x)dx, where q(x) is the probability density function of individual risk.",
            "startOffset": 9459,
            "title": "Relaxing the model and adjusting the data"
        },
        {
            "endOffset": 10016,
            "parents": [],
            "secId": "sec0010",
            "sentence": "Heterogeneity induces a cohort selection effect [12,13] whereby individuals at higher risk are infected first and leave behind less susceptible subjects.",
            "startOffset": 9863,
            "title": "Relaxing the model and adjusting the data"
        },
        {
            "endOffset": 12660,
            "parents": [],
            "secId": "sec0015",
            "sentence": "Fig. 1 shows information retrieved from published vaccine trials.",
            "startOffset": 12595,
            "title": "Observations from vaccine trials"
        },
        {
            "endOffset": 11739,
            "parents": [],
            "secId": "sec0010",
            "sentence": "The measured variations in vaccine effects can be reproduced when a plausible model is fitted to global data, stratified by country or some other unit that enables the specification of disease occurrence ratios by incidence.",
            "startOffset": 11515,
            "title": "Relaxing the model and adjusting the data"
        }
    ],
    "docId": "S0264410X16302304",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": "gabriela.gomes@lstmed.ac.uk",
                "first": "M. Gabriela M.",
                "initial": "M.G.M.",
                "last": "Gomes"
            },
            {
                "email": null,
                "first": "Stephen B.",
                "initial": "S.B.",
                "last": "Gordon"
            },
            {
                "email": null,
                "first": "David G.",
                "initial": "D.G.",
                "last": "Lalloo"
            }
        ],
        "doi": "10.1016/j.vaccine.2016.04.065",
        "firstpage": "3007",
        "issn": "0264410X",
        "lastpage": "3009",
        "openaccess": "Full",
        "pub_year": 2016,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Clinical trials: The mathematics of falling vaccine efficacy with rising disease incidence"
    }
}